Zydus Cadila says its ZyCoV-D vaccine had very good results in Phase 1 and 2 trials. Dosing of participants in Phase 3 has been completed and the data analysis process is underway. However, not a single vaccine using its unique platform has been approved anywhere in the world. ZyCoV-D is also a three-dose vaccine, which could post logistical and administration challenges and weigh on pricing.Status of Zydus Cadila’s Covid-19 vaccine, frontrunner for EUA, manufacturing capacities and challenges
Zydus Cadila says its ZyCoV-D vaccine had very good results in Phase 1 and 2 trials. Dosing of participants in Phase 3 has been completed and the data analysis process is underway. However, not a single vaccine using its unique platform has been approved anywhere in the world. ZyCoV-D is also a three-dose vaccine, which could post logistical and administration challenges and weigh on pricing.
Subscribe to:
Post Comments (Atom)
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
-
Google has tried for years to get Samsung, the world#39;s leading mobile device maker by units sold, to drop its own services and give grea...
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
No comments:
Post a Comment